Tesla (TSLA) is cutting China prices on the Model 3 and two Model Y variants, the EV giant announced overnight.X The Model 3 Rear Wheel Drive is now RMB 245,900 ($34,639), down 5.9% from RMB 261,400 ($36,822). The Model 3 All Wheel Drive comes down 3.9% to RMB 285,900 from RMB 297,400.Tesla is cutting the Model Y RWD price by 2.8% to RMB 258,900 from RMB 266,400. The Model Y LR is being trimmed 2.1% to RMB 299,900 from RMB 306,400.Tesla did not adjust the Model Y Performance in China, which remains RMB 363, ...

Finding the best growth stocks to buy is no easy task. But you can streamline your search by focusing on the three key factors for stock investing. In both bull and bear markets, regularly checking time-tested stock screens can help you put the best potential stock picks on your list of stocks to buy and watch. Heavily tracked names like Magnificent Seven stocks Apple (AAPL), Alphabet (GOOGL), Tesla (TSLA), Microsoft (MSFT), Nvidia (NVDA), Meta Platforms (META), Amazon.com (AMZN) and others will come on and ...

Palo Alto Networks Palo Alto Networks PANW $299.74 $10.243.54%25% IBD Stock Analysis Stock rebounding from 10-week line.Shares clearing 21-day to break downtrend. Composite Rating 99/99 Industry Group Ranking 4/197 Emerging Pattern PullbackPullbackA stock may pull back after a breakout, often to the 50-day line. A rebound from the first or second visit to the 50-day can be a buying opportunity, especially for existing holders to add some shares. Palo Alto Networks (PANW) is the IBD Stock of the Day as the ...

The stock market snapped out of a new-year pullback on Monday as the Nasdaq composite led broad gains and the market's supernovas helped brighten the investing landscape. X The Nasdaq rallied 2.2%, wiping out much of last week's 3.3% tumble in a single session. The S&P 500 also recovered the majority of last week's 1.5%… ...

Merck (MRK) stock is shrugging off seven months of underperformance, shooting more than 7% higher in the first week of 2024 on growing excitement for its post-Keytruda life.X And, in the second week of 2024, Merck announced the $680 million takeover of Harpoon Therapeutics (HARP). Harpoon is working in a bread-and-butter area for Merck: immuno-oncology. Its drugs are designed to direct the body's own immune system to kill cancer cells. Harpoon stock ran up by triple digits early Monday, while Merck shares d ...

Johnson & Johnson (JNJ), Merck (MRK) and Boston Scientific (BSX) kicked off the year's biggest medical conference with a trio of splashy takeovers topping $3 billion in combined value.X Health care behemoth J&J is spending $2 billion to buy Ambrx (AMAM), Merck pledged to pay $680 million for Harpoon Therapeutics (HARP) and medtech player Boston Scientific (BSX) is coughing up $3.7 billion for Axonics (AXNX). Novartis (NVS) is also buying privately held Calypso Biotech for $250 million up front.The deals all ...

Isomorphic Labs, a unit of Google-parent Alphabet (GOOGL), on Sunday announced strategic research collaborations with Eli Lilly (LLY) and Novartis (NVS). The Lilly and Novartis collaborations will focus on small-molecule treatments and multiple targets. Isomorphic Labs, which uses artificial intelligence to help discover new drugs, will receive upfront cash and possible milestone payments.X Eli Lilly and Isomorphic Labs will team up to discover small molecule therapeutics for multiple targets. Isomorphic wi ...

Amazon's (AMZN) massive growth spurt during the pandemic was followed by a sharp slump, with shares falling 49% last year. But the tech giant has turned it around in 2023, with Amazon stock up 83% as of market open Dec. 26.X The percent gain puts Amazon stock on pace for its best year since 2015. With a market cap nearing $1.6 trillion, Amazon is looking to build off gains this year by establishing leadership in generative artificial intelligence and improving the profitability of its massive online retail ...

While streaming video rivals consider consolidation to compete, Netflix (NFLX) continues to lead the market and is poised for a solid fourth-quarter performance, a Wall Street analyst said Thursday. Netflix stock dipped in afternoon trades.X Wedbush Securities analyst Alicia Reese reiterated her outperform rating on Netflix stock with a 12-month price target of 525. Further, Netflix is on the firm's "best ideas list."Netflix stock slid 0.3% to 487.83 on the stock market today."We think Netflix has reached t ...

Amazon (AMZN)'s advertising business is approaching $50 billion in annual sales, but it may still be early days for the division, according to Wedbush analysts who raised their target price for Amazon stock.Amazon "is well positioned to continue taking share of global digital advertising spending over a multi-year period," Wedbush analyst Scott Devitt told clients in a Wednesday note. The tech giant is on pace for $46.5 billion in advertising revenue this year, he added. Wedbush estimates Amazon's ad sales ...